Oracle
ORCL
Amazon
AMZN
Adobe
ADBE
Alphabet-C
GOOG
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 1.530
- +0.030+2.00%
Close Jan 21 16:00 ET
- 1.530
- 0.0000.00%
Post 16:05 ET
90.98MMarket Cap-1.44P/E (TTM)
1.560High1.480Low402.20KVolume1.500Open1.500Pre Close612.29KTurnover1.12%Turnover RatioLossP/E (Static)59.47MShares6.85052wk High0.59P/B55.01MFloat Cap1.39052wk Low--Dividend TTM35.95MShs Float19.000Historical High--Div YieldTTM5.33%Amplitude1.100Historical Low1.522Avg Price1Lot Size
Pyxis Oncology News
Pyxis Oncology | SCHEDULE 13D/A: Others
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Lara
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Connealy Pamela Ann
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Wadhane Jitendra
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | SCHEDULE 13G: Others
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Connealy Pamela Ann
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pyxis Oncology | 10-Q: Q3 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurion Capital Management LP(6.15%),Benjamin Alexander Smith(6.15%), etc.
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bayer World Investments B.V.(4.7%),Bayer Aktiengesellschaft(4.7%)
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | DEF 14A: Definitive information statements
Pyxis Oncology | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Pyxis Oncology | 10-Q: Q2 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Metzger Michael A
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.